Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 2
2008 2
2010 1
2013 1
2017 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
Pentosidine effects on human osteoblasts in vitro.
Sanguineti R, Storace D, Monacelli F, Federici A, Odetti P. Sanguineti R, et al. Among authors: storace d. Ann N Y Acad Sci. 2008 Apr;1126:166-72. doi: 10.1196/annals.1433.044. Ann N Y Acad Sci. 2008. PMID: 18448811
Effects of valsartan therapy on protein glycoxidation.
Monacelli F, Poggi A, Storace D, Durante A, Traverso N, Viviani GL, Odetti P. Monacelli F, et al. Among authors: storace d. Metabolism. 2006 Dec;55(12):1619-24. doi: 10.1016/j.metabol.2006.07.024. Metabolism. 2006. PMID: 17142134
PKC delta and NADPH oxidase in AGE-induced neuronal death.
Nitti M, Furfaro AL, Traverso N, Odetti P, Storace D, Cottalasso D, Pronzato MA, Marinari UM, Domenicotti C. Nitti M, et al. Among authors: storace d. Neurosci Lett. 2007 Apr 18;416(3):261-5. doi: 10.1016/j.neulet.2007.02.013. Epub 2007 Feb 9. Neurosci Lett. 2007. PMID: 17317001
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial.
Vaccaro O, Masulli M, Nicolucci A, Bonora E, Del Prato S, Maggioni AP, Rivellese AA, Squatrito S, Giorda CB, Sesti G, Mocarelli P, Lucisano G, Sacco M, Signorini S, Cappellini F, Perriello G, Babini AC, Lapolla A, Gregori G, Giordano C, Corsi L, Buzzetti R, Clemente G, Di Cianni G, Iannarelli R, Cordera R, La Macchia O, Zamboni C, Scaranna C, Boemi M, Iovine C, Lauro D, Leotta S, Dall'Aglio E, Cannarsa E, Tonutti L, Pugliese G, Bossi AC, Anichini R, Dotta F, Di Benedetto A, Citro G, Antenucci D, Ricci L, Giorgino F, Santini C, Gnasso A, De Cosmo S, Zavaroni D, Vedovato M, Consoli A, Calabrese M, di Bartolo P, Fornengo P, Riccardi G; Thiazolidinediones Or Sulfonylureas Cardiovascular Accidents Intervention Trial (TOSCA.IT) study group; Italian Diabetes Society. Vaccaro O, et al. Lancet Diabetes Endocrinol. 2017 Nov;5(11):887-897. doi: 10.1016/S2213-8587(17)30317-0. Epub 2017 Sep 13. Lancet Diabetes Endocrinol. 2017. PMID: 28917544 Clinical Trial.